- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Trametinib placebo
Total 53721 results
-
Melanoma Institute AustraliaNovartisRecruiting
-
Novartis PharmaceuticalsCompletedMelanomaCanada, Spain, United Kingdom, Netherlands, United States, Argentina, Australia, France, Germany, Greece, Italy, Russian Federation, Sweden, Ukraine
-
Memorial Sloan Kettering Cancer CenterCompletedNon Small Cell Lung Cancer | KRAS Gene MutationUnited States
-
Novartis PharmaceuticalsRecruitingDifferentiated Thyroid CancerChina, Korea, Republic of, Taiwan, India, Malaysia, Turkey, Canada, Vietnam, Argentina, Brazil, Mexico, United States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
Stanford UniversityBoston Children's HospitalRecruitingArterial Disease | Venous MalformationUnited States
-
The Netherlands Cancer InstituteGlaxoSmithKlineUnknown
-
Shanghai Henlius BiotechRecruiting
-
University Health Network, TorontoNot yet recruitingArteriovenous Malformations
-
Dana-Farber Cancer InstituteNovartis; National Comprehensive Cancer NetworkTerminated
-
Universitair Ziekenhuis BrusselCompleted
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineCompletedUnresectable Melanoma | Stage IV Melanoma | Stage III Melanoma | BRAF Mutant MelanomaUnited States
-
Adil DaudNational Comprehensive Cancer NetworkCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGastric Cancer | Metaplasia | Stage I Gastric Cancer | Initial-onset Gastric CancerJapan
-
Jonsson Comprehensive Cancer CenterNovartisNo longer availableProgressive Metastatic Castrate Resistant Prostate Cancer
-
Asan Medical CenterUnknownCancer | Lung Cancer Metastatic | BRAF V600EKorea, Republic of
-
GlaxoSmithKlineCompleted
-
Leiden University Medical CenterNovartisRecruitingAnaplastic Thyroid CancerNetherlands
-
Novartis PharmaceuticalsCompletedMalignant MelanomaPortugal
-
Novartis PharmaceuticalsRecruitingBRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid TumorJapan
-
University Hospital, EssenRecruitingMetastatic Thyroid CancerGermany
-
Novartis PharmaceuticalsRecruitingMelanoma | Solid Tumor | High Grade Glioma | Non Small Cell Lung Cancer | Rare CancersSpain, Germany, United States, Argentina, Austria, Denmark, France, Hungary, Netherlands, China, Japan, Thailand
-
Sun Yat-sen UniversityNot yet recruitingNSCLC | BRAF V600 Mutation | MET Exon 14 MutationChina
-
GenfitRecruitingCholangiocarcinomaUnited States, Puerto Rico
-
Novartis PharmaceuticalsRecruiting
-
Novartis PharmaceuticalsRecruiting
-
Novartis PharmaceuticalsAvailable
-
Poitiers University HospitalCompletedUnresecable Stage IIIc or IV MelanomaFrance
-
EuMelaReg gGmbHActive, not recruiting
-
Novartis PharmaceuticalsAvailable
-
Saint Petersburg State University, RussiaRecruitingAnaplastic Thyroid CancerRussian Federation
-
Eva Marie Erfurth, MD, PhDNovartisRecruiting
-
Novartis PharmaceuticalsRecruitingGlioblastoma | Astrocytoma | Anaplastic Astrocytoma | Neurofibromatosis Type 1 | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma... and other conditionsUnited States, Belgium, Spain, Denmark, Germany, Czechia, Italy, Australia, Russian Federation, France, Netherlands, Japan, Canada, Finland, Sweden, United Kingdom, Argentina, Israel, Brazil
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
Haukeland University HospitalBerGenBio ASAActive, not recruiting
-
GlaxoSmithKlineTerminatedMelanoma and Brain MetastasesUnited States, Australia
-
Merrimack PharmaceuticalsTerminatedColorectal Cancer | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung CancerUnited States
-
Nanjing Yoko Biomedical Co., Ltd.Unknown
-
National University Hospital, SingaporeSingapore General HospitalUnknown
-
Hospices Civils de LyonUnknownMetastatic NRAS MelanomaFrance
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Novartis PharmaceuticalsRecruitingCarcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Colorectal Cancer | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Carcinoma, Non-Small Cell Lung | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal | Non-Small Cell Lung Carcinoma | KRAS G12C Mutant Solid TumorsKorea, Republic of, Spain, Belgium, United States, France, Germany, Italy, Singapore
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkCompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Genuv Inc.TerminatedAmyotrophic Lateral SclerosisKorea, Republic of
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma (Locally Advanced) | Stage IIC Melanoma (Locally Advanced) | Stage IV Melanoma (Limited, Resectable)United States
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Canada, Spain, United Kingdom, Netherlands, Argentina, Australia, Austria, Brazil, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, New Zealand, Norway, Poland, Russian Federation, Sweden, Switz... and more